Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 117
Filter
1.
Oxid Med Cell Longev ; 2021: 8026941, 2021.
Article in English | MEDLINE | ID: mdl-33603952

ABSTRACT

DLBCL is the most common type of non-Hodgkin lymphoma with a substantial group of patients suffering a poor prognosis. Therefore more specific markers are required for better understanding of disease biology and treatment. This study demonstrates that testis-specific antioxidant enzymes TXNDC2, TXNDC3, and TXNDC6 alongside oxidative stress marker 8-OHdG are expressed in both testicular and systemic DLBCL, and their presence or absence has correlations with clinical risk factors such as the number of extranodal effusion, the appearance of B-symptoms, and treatment response. Biopsy samples were collected from 28 systemic and 21 testicular male DLBCL patients. The samples were histostained with TXNDC2, TXNDC3, TXNDC6, and 8-OHdG, then graded by a hematopathologist blinded to clinical data. Immunoelectron microscopy was used as a second method to confirm the reliability of the acquired immunohistochemistry data. The absence of nuclear TXNDC2 expression in testicular DLBCL cells correlated with worse primary treatment response, cytoplasmic TXNDC3 expression in testicular and systemic DLBCL associated with lower frequency of B-symptoms, and TXNDC6 expression in cytoplasm in systemic DLBCL had a clinical significance with higher LD levels suggesting a role in the biological nature of these lymphomas. Overall, TXNDC3 cytoplasmic expression is correlated with a more positive outcome in both testicular and systemic DLBCL, while TXNDC6 cytoplasmic expression is associated with a negative outcome in systemic DLBCL.


Subject(s)
Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Large B-Cell, Diffuse/pathology , Membrane Proteins/metabolism , Testicular Neoplasms/metabolism , Testicular Neoplasms/pathology , Testis/metabolism , Thioredoxins/metabolism , 8-Hydroxy-2'-Deoxyguanosine/metabolism , Cell Line, Tumor , Humans , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Male , Middle Aged , Organ Specificity , Testicular Neoplasms/ultrastructure , Testis/pathology , Testis/ultrastructure
3.
Chin J Cancer ; 29(6): 579-84, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20507729

ABSTRACT

BACKGROUND AND OBJECTIVE: In recent years, incidence and mortality of lymphoma are markedly increasing worldwide. However, the pathogenesis and mechanism of invasion and metastasis for lymphoma are not yet fully clarified. It is mainly due to the lack of ideal animal models, which can precisely simulate the invasion and metastasis of lymphoma in the human body. So, it is very necessary to establish a highly metastatic nude mouse model of human lymphoma. This study developed a liver-metastatic model of primary gastric lymphoma in nude mice by using orthotopic surgical implantation of histologically intact patient specimens into the corresponding organs of the recipient small animals. METHODS: A histologically intact fragment of liver metastasis derived from a surgical specimen of a patient with primary gastric lymphoma was implanted into the submucosa of the stomach in nude mice. Tumorigenicity, invasion, metastasis, morphologic characteristics (via light microscopy, electron microscopy, and immunohistochemistry), karyotype analysis, and DNA content of the orthotopically transplanted tumors were studied. RESULTS: An orthotopic liver metastatic model of human primary gastric lymphoma in nude mice (termed HGBL-0304) was successfully established. The histopathology of the transplanted tumors showed primary gastric diffuse large B-cell lymphoma. CD19, CD20, CD22, and CD79alpha were positive, but CD3 and CD7 were negative. The serum level of lactate dehydrogenase (LDH) was elevated [(1010.56+/-200.85) U/L]. The number of chromosomes ranged from 75 to 89. The DNA index (DI) was 1.45+/-0.25 (that is, heteroploid). So far, the HGBL-0304 model has been passed on for 45 generations of nude mice. A total of 263 nude mice were used for the transplantation. Both the growth and resuscitation rates of liquid nitrogen cryopreservation of the transplanted tumors were 100%. The transplanted tumors autonomically invasively grew and damaged a whole layer in the stomach of nude mice. The metastasis rates of liver, spleen, lymph node, and peritoneal seeding were 100%, 94.3%, 62.6%, and 43.5%, respectively. CONCLUSIONS: The study successfully establishes an orthotopic liver metastatic model of human primary gastric lymphoma in nude mice. The HGBL-0304 model can completely simulate the natural clinical process of primary gastric lymphoma and provides an ideal animal model for the research on the biology of metastasis and antimetastatic experimental therapies of primary gastric lymphoma.


Subject(s)
Disease Models, Animal , Liver Neoplasms/secondary , Lymphoma, Large B-Cell, Diffuse/pathology , Stomach Neoplasms/pathology , Aged , Aneuploidy , Animals , Antigens, CD/metabolism , CD79 Antigens/metabolism , Humans , L-Lactate Dehydrogenase/blood , Liver/pathology , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Liver Neoplasms/ultrastructure , Lymphatic Metastasis , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Invasiveness , Neoplasm Transplantation , Splenic Neoplasms/secondary , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism
4.
Endocr Pathol ; 20(1): 46-9, 2009.
Article in English | MEDLINE | ID: mdl-19229666

ABSTRACT

We report the case of a 62-year-old man with headache and left sixth cranial nerve palsy. A computerized tomography scan revealed an osteolytic process involving the sella turcica and clivus. A partial tumor resection was achieved via an endoscopic transsphenoidal approach. Morphologic investigation revealed a diffuse large B cell lymphoma involving pituitary parenchyma. No systemic disease was found upon staging. Primary pituitary lymphoma is extremely rare. An accurate histologic diagnosis is key to successful treatment and a favorable prognosis. The literature is reviewed.


Subject(s)
Lymphoma, Large B-Cell, Diffuse/ultrastructure , Pituitary Neoplasms/ultrastructure , Humans , Immunohistochemistry , Lymphoma, Large B-Cell, Diffuse/metabolism , Male , Microscopy, Electron, Transmission , Middle Aged , Pituitary Neoplasms/metabolism , Tomography, X-Ray Computed
5.
J Clin Pathol ; 62(9): 840-4, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19126565

ABSTRACT

A case of CD30-positive microvillous lymphoma (MVL) in an 87-year-old man who was encountered generalised lymphadenopathy is presented. Histopathologically, the tumour showed a morphological mimic of anaplastic large cell lymphoma (ALCL) with sinusoidal growth pattern. Immunohistochemically (IHC), the tumour cells were CD30(+), CD20(+), CD45(+), BCL-2(+), BCL-6(+), MUM1(+), Ki-67(+), CD45RO(-), CD3(-), CD10(-), CD15(-), CD56(-), EMA(-), TIA-1(-) and ALK(-). Flow cytometry confirmed the IHC. In situ hybridisation for Epstein-Barr virus RNA was negative. Electron microscopically, the tumour cells were similar to large transformed lymphocytes and had circumferentially profuse microvillous projections resembling those of epithelial mesothelioma cells. In conclusion, CD30-positive MVLs are indistinguishable from ALCLs that have ultrastructural microvillous projections by morphology alone. However, the lack of EMA, TIA-1 and ALK expression in this MVL case facilitated a definite distinction from ALCLs. The results of a panel of three markers (CD10(-), Bcl-6(+) and MUM1(+)) suggested that the present case of CD30-positive MVLs has an activated non-germinal centre B-cell origin.


Subject(s)
Ki-1 Antigen/analysis , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Aged, 80 and over , Biomarkers, Tumor/analysis , Diagnosis, Differential , Humans , Lymphoma, Large B-Cell, Diffuse/diagnosis , Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Large-Cell, Anaplastic/diagnosis , Male , Microscopy, Electron , Microvilli/ultrastructure
6.
Pathol Res Pract ; 205(4): 279-82, 2009.
Article in English | MEDLINE | ID: mdl-19059735

ABSTRACT

Rosette formation is an unusual finding in malignant lymphomas. We herein report another case of a diffuse large B-cell lymphoma (DLBCL) with ultrastructural evidence of cellular projections, sinusoidal growth pattern, and strong CD30 expression. A literature review of the DLBCL cases showing all these features was also performed.


Subject(s)
Ki-1 Antigen/metabolism , Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Aged , Biomarkers, Tumor/analysis , Female , Humans , Microscopy, Electron, Transmission
7.
Ultrastruct Pathol ; 30(6): 427-33, 2006.
Article in English | MEDLINE | ID: mdl-17182435

ABSTRACT

Plasmablastic lymphoma was originally described in 1997 by Delecluse et al. and is an aggressive variant of diffuse large B-cell non-Hodgkin lymphoma seen predominantly in a setting of acquired immunodeficiency syndrome and nearly always in extranodal sites. The authors have seen 10 cases in their department between 2001 and 2005. The patients' ages ranged from 24 to 39 years and there were 7 females and 3 males. In 7 cases where human immunodeficiency virus had been tested it was positive. Eight cases were extranodal and 2 cases involved lymph nodes. Five cases were followed up and 4 were confirmed dead within 5 months of diagnosis, verifying the aggressive nature of this condition. Histology showed large, polygonal tumor cells some of which had a slightly plasmacytic appearance. Six cases had a "starry sky" background. Immunohistochemical stains were negative in 1 case, while the other 9 cases were positive for CD138. Electron microscopy showed concentrically arranged rough endoplasmic reticulum in the cytoplasm in 9 cases. In 1 case the cells were too degenerate for evaluation. This study shows that the ultrastructural features are well developed and can help in distinguishing plasmablastic lymphoma from other light microscopically undifferentiated tumors.


Subject(s)
HIV Infections/complications , Lymphoma, B-Cell/ultrastructure , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Adult , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/metabolism , Lymphoma, Large B-Cell, Diffuse/complications , Lymphoma, Large B-Cell, Diffuse/metabolism , Male , Microscopy, Electron, Transmission , Multiple Myeloma/pathology , Plasmacytoma/pathology , Syndecan-1/metabolism
9.
Int J Oncol ; 27(3): 867-74, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16077940

ABSTRACT

Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and binds to a variety of receptors, which recently have also been detected in peripheral, non-excitable cells. New research suggests that this abundant amino acid might also be involved in the growth of tumor cells acting via novel receptor-mediated autocrine/paracrine signal transduction pathways. We report here that glutamate, as well as glutamate receptor reactive drugs, differentially modulate growth and morphology of human histiocytic lymphoma-derived U937 cells. These effects were different depending on the culture milieu: in glutamine-free medium the glutamate receptor agonists, kainate (KA), and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), but also the antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), significantly decreased the proliferation of U937 cells. In contrast, in cultures devoid of glutamate, glutamine and serum, the agonists significantly increased cell proliferation whereas the antagonist CNQX showed no effect. These data point to a significant role of peripheral glutamate receptors in tumor cell proliferation.


Subject(s)
Cell Proliferation/drug effects , Glutamic Acid/pharmacology , Receptors, Glutamate/physiology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Cell Shape/drug effects , Culture Media, Serum-Free/pharmacology , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Glutamine/pharmacology , Humans , Kainic Acid/pharmacology , Lymphoma, Large B-Cell, Diffuse/pathology , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Microscopy, Electron , Time Factors , U937 Cells , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology
12.
Am J Pathol ; 160(6): 1967-72, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12057901

ABSTRACT

Fluorescence in situ hybridization (FISH) is difficult to accomplish using thin-sections of paraffin-embedded lymphoid tissue because of the high cellularity and truncated cells that interfere with accurate scoring of individual nuclei. We modified and tested a new technique to isolate individual nuclei from tissue cores of paraffin-embedded tissue processed with xylene, proteinase K, citric acid, and pepsin. The efficacy of this method to study paraffin-embedded tissue was investigated in six normal lymph nodes or tonsils and 32 malignant lymphomas including five mantle cell, five follicular, five Burkitt, five extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue, five anaplastic large-cell, and seven diffuse large B-cell. Fusion of CCND1 and IgH, BCL2 and IgH, c-myc and IgH, and MALT1 and API2 were detected using probes with a dual-fusion FISH strategy. Anomalies involving ALK and BCL6 were detected using break-apart FISH probes. FISH studies were successful for each of the 38 specimens. Chromosome anomalies were detected in each malignant specimen, but not in the normal lymphoid tissue. The correct chromosome anomaly was detected in 22 of 22 specimens with genetic abnormalities that were established by other genetic techniques. This FISH technique is useful to detect chromosome anomalies with high sensitivity and specificity in paraffin-embedded tissue and may provide important diagnostic and prognostic genetic information.


Subject(s)
Cell Nucleus/ultrastructure , In Situ Hybridization, Fluorescence/methods , Lymphoma/ultrastructure , Burkitt Lymphoma/genetics , Burkitt Lymphoma/ultrastructure , Chromosome Aberrations , Humans , Lymph Nodes/ultrastructure , Lymphoma/genetics , Lymphoma, B-Cell, Marginal Zone/genetics , Lymphoma, B-Cell, Marginal Zone/ultrastructure , Lymphoma, Follicular/genetics , Lymphoma, Follicular/ultrastructure , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Lymphoma, Mantle-Cell/genetics , Lymphoma, Mantle-Cell/ultrastructure , Palatine Tonsil/ultrastructure , Paraffin Embedding/methods
13.
Virchows Arch ; 438(3): 280-8, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11315625

ABSTRACT

Comparative immunohistochemical and ultrastructural studies were performed on five nasal natural killer (NK) cell lymphoma cases, two intestinal T-cell lymphoma cases, and eight anaplastic large cell lymphoma (ALCL) cases to clarify morphological differences in cytotoxic granules among these cytotoxic lymphomas. Nasal NK-cell lymphomas and intestinal T-cell lymphomas had fine azurophilic granules and displayed dot-like immunostaining of granzyme B- and T-cell intracellular antigen 1 (TIA-1), predominantly in the central area of the cytoplasm. Ultrastructurally, these NK-cell lymphomas and intestinal T-cell lymphomas had two types of cytotoxic granules, type-I granules (dense core granules) and type-II granules (multivesicular bodies), which have been demonstrated in normal large granular lymphocytes in peripheral blood. However, ALCLs did not have azurophilic granules, and only type-II cytotoxic granules were found ultrastructurally, even though they showed similar dot-like immunostained patterns of granzyme B and TIA-1, as seen in NK-cell lymphomas and intestinal T-cell lymphomas. Immunoelectron microscopy revealed that TIA-1 was primarily located at the periphery of the cytoplasmic granules in the NK-cell lymphoma and ALCL cases. These findings suggest that malignant lymphomas with a cytotoxic phenotype can be divided into two types, (azurophilic granule)+, (type-I granule)+, (type-II granule)+ lymphomas and (azurophilic granule)-, (type-I granule)-, (type-II granule)+ lymphomas.


Subject(s)
Cytoplasmic Granules/ultrastructure , Intestinal Neoplasms/ultrastructure , Killer Cells, Natural/ultrastructure , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Lymphoma, T-Cell/ultrastructure , Nose Neoplasms/ultrastructure , Proteins , Adult , Aged , CD56 Antigen/analysis , Cytoplasmic Granules/immunology , Female , Humans , Intestinal Neoplasms/immunology , Killer Cells, Natural/immunology , Lymphoma, Large B-Cell, Diffuse/immunology , Lymphoma, T-Cell/immunology , Male , Membrane Proteins/analysis , Microscopy, Immunoelectron , Middle Aged , Nose Neoplasms/immunology , Poly(A)-Binding Proteins , RNA-Binding Proteins/analysis , T-Cell Intracellular Antigen-1
14.
Eur J Cancer ; 37(2): 260-7, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11166155

ABSTRACT

CHS 828, a novel pyridyl cyanoguanidine, has shown potent antitumour activity both in vitro and in vivo and is currently undergoing phase I evaluation in humans in collaboration with the European Organization for Research and Treatment of Cancer (EORTC). Here we study the temporal effects of CHS 828 on cytotoxicity, protein and DNA synthesis, cellular morphology and ultra structure using the lymphoma cell line U-937 GTB as the primary tumour model. In vitro analysis of tumour cell survival in response to CHS 828 revealed a cytotoxic effect progressively increased as a function of exposure time with maximum efficacy observed after 72 h. Activity of CHS 828 on U-937 GTB cells grown in vivo was also found. CHS 828 induced-cell death was dependent on intact protein synthesis and most cells appeared to lose their membrane integrity in the presence of a relatively well preserved nuclear structure. The results indicate that CHS 828 induced active and delayed cell death with a non-apoptotic morphology.


Subject(s)
Antineoplastic Agents/therapeutic use , Cyanides/therapeutic use , Guanidines/therapeutic use , Lymphoma, Large B-Cell, Diffuse/drug therapy , Cell Death , Cell Survival , Dose-Response Relationship, Drug , Flow Cytometry/methods , Humans , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Microscopy, Electron , Tumor Cells, Cultured
15.
Ultrastruct Pathol ; 23(5): 333-9, 1999.
Article in English | MEDLINE | ID: mdl-10582271

ABSTRACT

A 56-year-old white woman, seropositive for human immunodeficiency virus for 18 months without signs of acquired immunodeficiency syndrome, presented with retrosternal pain and progressive dysphagia secondary to an exophytic esophageal mass. Biopsies of the tumor showed a malignant neoplasm composed of pleomorphic, noncohesive cells growing in a diffuse, sheet-like fashion. Immunohistochemically, tumor cells were nonreactive with epithelial, lymphoid, neural, and monocyte/macrophage markers. Despite the noncontributory immunohistochemical findings, ultrastructural study of the tumor cells revealed convincing histiocytic features. Individual cells possessed long, slender filopodial projections, prominent Golgi apparatus, residual bodies, rare lysosomes, and prelysosomes. Immunoglobulin heavy chain and T-cell receptor gamma gene rearrangement studies detected no evidence of a clonal gene rearrangement. The patient responded poorly to chemotherapy and died 5 months after her initial symptom of dysphagia.


Subject(s)
Esophageal Neoplasms/ultrastructure , HIV Infections/pathology , Lymphoma, AIDS-Related/ultrastructure , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Antineoplastic Agents/therapeutic use , Biomarkers, Tumor/analysis , Esophageal Neoplasms/chemistry , Esophageal Neoplasms/drug therapy , Fatal Outcome , Female , HIV Infections/drug therapy , HIV Seropositivity , Humans , Immunocompromised Host , Immunoenzyme Techniques , Lymphoma, AIDS-Related/chemistry , Lymphoma, Large B-Cell, Diffuse/chemistry , Lymphoma, Large B-Cell, Diffuse/drug therapy , Microscopy, Electron , Middle Aged , Tomography, X-Ray Computed , Zidovudine/therapeutic use
16.
Pathol Res Pract ; 195(2): 81-7, 1999.
Article in English | MEDLINE | ID: mdl-10093826

ABSTRACT

The purpose of this work is to study the presence of cell junction-like structures in large B-cell lymphomas. The ultrastructural study, based on 20 cases of this entity proved by immunohistochemistry and flow cytometry, demonstrated four types of junction-like devices easily found between tumor cells. Several explanations are offered about the possible nature of such structures, including the possibility of them being the result of adhesion phenomena. It should also be emphasized that they can potentially complicate the differential diagnosis of those neoplasms. We should, therefore, be careful in rejecting an ultrastructural diagnosis of large B-cell lymphoma based only on the presence of junction-like structures.


Subject(s)
Gap Junctions/ultrastructure , Lymphoma, B-Cell/ultrastructure , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Biomarkers, Tumor/analysis , Flow Cytometry , Humans , Immunohistochemistry , Lymphoma, B-Cell/chemistry , Lymphoma, Large B-Cell, Diffuse/chemistry , Microscopy, Electron
17.
Ultrastruct Pathol ; 22(1): 55-62, 1998.
Article in English | MEDLINE | ID: mdl-9491216

ABSTRACT

Electron microscopy can be used to establish diagnoses in some otherwise difficult cases of neoplasia, but it is not generally regarded as important in the diagnosis of lymphoma. However, in some cases of anaplastic tumors not initially recognized as lymphomas, electron microscopy can prove quite valuable. Two cases are reported in which lymphoma was not suspected on the basis of the histologic findings, but was diagnosed by electron microscopy. Case 1 involved a 60-year-old woman who presented with a retroperitoneal mass that was located primarily in the body of the psoas muscle. Nuclear pockets were seen with electron microscopy. Ultimately she was diagnosed with anaplastic large-cell lymphoma (Ki-1 lymphoma). Case 2 involved a 43-year-old male with retroperitoneal lymphadenopathy, renal failure, polyclonal gammopathy, and a febrile illness. Signet-ring cells without junctions were identified with electron microscopy. Immunoperoxidase stains confirmed diffuse large-cell immunoblastic lymphoma.


Subject(s)
Lymphoma/diagnosis , Adult , Antigens, Differentiation, B-Lymphocyte/analysis , Antigens, Differentiation, T-Lymphocyte/analysis , Female , Humans , Immunoenzyme Techniques , Immunoglobulin M/analysis , Immunophenotyping , Keratins/analysis , Ki-1 Antigen/analysis , Leukocyte Common Antigens/analysis , Lymphoma/immunology , Lymphoma/ultrastructure , Lymphoma, Large B-Cell, Diffuse/diagnosis , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Lymphoma, Large-Cell, Anaplastic/diagnosis , Lymphoma, Large-Cell, Anaplastic/ultrastructure , Lymphoma, Large-Cell, Immunoblastic/diagnosis , Lymphoma, Large-Cell, Immunoblastic/ultrastructure , Male , Microscopy, Electron , Middle Aged , Paraffin Embedding
18.
Pathol Int ; 48(12): 974-80, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9952342

ABSTRACT

Interdigitating reticulum cell (IRC) tumor is a rare tumor arising from the antigen-presenting cell - interdigitating reticulum cell. A 41-year-old male presented with lumps in the left neck and bone pain. Further investigations revealed multiple left neck and para-aortic lymphadenopathy, and multiple bony lesions. Histological examination of the lymph node showed proliferation of unusual, large, round neoplastic cells mimicking large cell lymphoma. Immunophenotypic and ultrastructural studies confirmed this tumor to be arising from an interdigitating reticulum cell. A review of reported IRC tumors illustrates the variability of this tumor in clinical and pathological features, which differ from other dendritic reticulum cell tumors.


Subject(s)
Lymph Nodes/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Adult , Biomarkers, Tumor/metabolism , Herpesvirus 4, Human/isolation & purification , Humans , Immunohistochemistry , In Situ Hybridization , Lymph Nodes/metabolism , Lymph Nodes/ultrastructure , Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Male , Microscopy, Electron , RNA, Viral/metabolism
19.
Cell Growth Differ ; 8(10): 1071-82, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9342185

ABSTRACT

Retinoids have been shown to modulate cell growth and differentiation in a variety of human tumor cell types, but their effects on B-cell non-Hodgkin's lymphomas (NHL-B) have not been explored. In this study, all-trans retinoic acid (ATRA) in the free form and liposome-encapsulated form (L-ATRA) were used to determine effects on fresh NHL-B patient cells as well as cell lines recently established from both HIV-negative and -positive NHL-B patient biopsies. Both ATRA and L-ATRA were found to inhibit cell proliferation in NHL-B cells. However, L-ATRA was found to be superior to free ATRA in inhibiting cell proliferation of NHL-B cells and resulted in greater than 90% cell growth inhibition in a dose-dependent manner. In addition, L-ATRA also induced high levels of apoptosis in NHL-B cells in vitro. To delineate the apoptotic pathways involved, the expression of the apoptosis suppressor oncogene bcl-2 was evaluated in different NHL-B cells with and without the t(14;18) chromosomal translocation. After L-ATRA exposure, more than a 50% reduction in the expression of bcl-2 protein was observed. bcl-2 message levels were also down-regulated in the L-ATRA-sensitive NHL-B cells. Bax protein levels were analyzed and found to be up-regulated in L-ATRA-sensitive NHL-B cells. Similar results were observed in sensitive AIDS/lymphoma cell lines. Experiments using an RAR-alpha antagonist (RO 41-5253) showed that both the proliferation inhibition and apoptosis induced by L-ATRA could be blocked in NHL-B cells. The findings of the present study indicate that L-ATRA may possess therapeutic potential in blocking cell proliferation, inducing apoptosis, and


Subject(s)
Apoptosis , Cell Division/drug effects , Lymphoma, B-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Tretinoin/administration & dosage , Tretinoin/pharmacology , Benzoates/pharmacology , Blotting, Western , Chromans/pharmacology , Dosage Forms , Down-Regulation , Gene Expression Regulation, Neoplastic/drug effects , Humans , Liposomes/administration & dosage , Lymphoma, AIDS-Related/pathology , Lymphoma, B-Cell/drug therapy , Lymphoma, B-Cell/ultrastructure , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Microscopy, Electron , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Receptors, Retinoic Acid/antagonists & inhibitors , Receptors, Retinoic Acid/physiology , Retinoic Acid Receptor alpha , Tumor Cells, Cultured , bcl-2-Associated X Protein
20.
Leuk Lymphoma ; 23(5-6): 613-5, 1996 Nov.
Article in English | MEDLINE | ID: mdl-9031094

ABSTRACT

Because of the characteristic presentation of primary mediastinal large cell lymphoma (PMLCL) in young females its known origin from thymic B-cells, there might be a role in lymphomagenesis for estrogen receptors as well as for known neuroendocrine thymic mediators. A retrospective review of all patients with diffuse large cell lymphoma seen at our institution from January 1985 to January 1994 revealed 75 consecutive cases with a diagnosis of PMLCL. Through retrieval from our pathologic archives and requests to outside pathologists, we recovered and analyzed 17 biopsy specimens for the presence of the following hormone receptors: estrogen, beta endorphin, prolactin, T3, growth hormone, and leutinizing hormone. None of the specimens stained for any of the reagents. The most plausible explanation is that PMLCL tissues are devoid of these hormonal receptors and thus these receptors do not seem to play a role in the pathogenesis of PMLCL.


Subject(s)
Lymphoma, Large B-Cell, Diffuse/ultrastructure , Mediastinal Neoplasms/ultrastructure , Receptors, Cell Surface/analysis , Biopsy , Female , Humans , Lymphoma, Large B-Cell, Diffuse/pathology , Mediastinal Neoplasms/pathology , Paraffin Embedding , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...